Clinical Trial Update: Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

View source ↗

Summary

An exploratory clinical evaluation using personalized functional profiling to predict drug response in colorectal cancer and pancreatic ductal adenocarcinoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Luxembourg Institute of Health | Conditions: Colorectal Cancer, PDAC - Pancreatic Ductal Adenocarcinoma | Status: NOT_YET_RECRUITING